Status: Recruiting
CPI-0209 Plus Carboplatin in Patients With Platinum Sensitive Recurrent Ovarian Cancer
This is a clinical trial using CPI-0209 in combination with Carboplatin chemotherapy followed by CPI-0209 maintenance in patients with platinum sensitive, recurrent ovarian cancer.
Participants needed: 30
Trial details
Phase: Phase 1Age: 18+Biological sex: FemaleType: InterventionalSponsor: Lan CoffmanUpdated: Jun 19, 2025Locations: 1
Eligibility criteria
Patients with platinum-sensitive recurrent ovarian, fallopian or primary periton... [+19]
Borderline or low malignant potential histology [+17]